Literature DB >> 10588771

Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases.

B Murgue1, X Deparis, E Chungue, O Cassar, C Roche.   

Abstract

We conducted a retrospective study of 403 laboratory-confirmed dengue cases hospitalized in Tahiti between August 1989 and March 1997. According to standard WHO criteria, 337 of these cases were dengue fever (DF) and 64 were dengue haemorrhagic fever (DHF). Of the 10 fatal cases, 6 were DF and 4 were DHF. As an alternative, we used a correspondence analysis procedure to define dengue severity based on basic clinical and biological criteria for which we assigned a severity score, and then selected the 50 most severe cases from this analysis. Of the latter, 17 patients had been classified as DF and 33 as DHF by the WHO criteria. From this analysis, haemorrhages and decreased platelets counts associated with hepatic disorders are the main criteria associated with the severe dengue cases. Thus in our study population, the WHO classification does not account for the overall severity of dengue; hepatic failure should be considered as a specific severe form of dengue since plasma leakage, which is the pathophysiological hallmark of DHF, is only one of the pathogenic mechanisms leading to severity.

Entities:  

Mesh:

Year:  1999        PMID: 10588771     DOI: 10.1046/j.1365-3156.1999.00478.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  18 in total

1.  Evaluation of the 2009 WHO dengue case classification in an Indonesian pediatric cohort.

Authors:  Cornelia A M van de Weg; Eric C M van Gorp; Mohamad Supriatna; Augustinus Soemantri; Albert D M E Osterhaus; Byron E E Martina
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

2.  Homology of complete genome sequences for dengue virus type-1, from dengue-fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaii and French Polynesia.

Authors:  A Imrie; C Roche; Z Zhao; S Bennett; M Laille; P Effler; V-M Cao-Lormeau
Journal:  Ann Trop Med Parasitol       Date:  2010-04

3.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Clinical presentation of dengue by serotype and year of epidemic in Martinique.

Authors:  Laurent Thomas; Fatiha Najioullah; François Besnier; Ruddy Valentino; Raymond Césaire; Jacques Rosine; Jacques Rosine Raymond Césaire; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

5.  Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

Authors:  P Koraka; C Suharti; T E Setiati; A T Mairuhu; E Van Gorp; C E Hack; M Juffrie; J Sutaryo; G M Van Der Meer; J Groen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum.

Authors:  Philippe Dussart; Bhety Labeau; Gisèle Lagathu; Philippe Louis; Marcio R T Nunes; Sueli G Rodrigues; Cécile Storck-Herrmann; Raymond Cesaire; Jacques Morvan; Marie Flamand; Laurence Baril
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

7.  Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators.

Authors:  James A Potts; Robert V Gibbons; Alan L Rothman; Anon Srikiatkhachorn; Stephen J Thomas; Pra-On Supradish; Stephenie C Lemon; Daniel H Libraty; Sharone Green; Siripen Kalayanarooj
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

8.  Clinical Features Of Acute Febrile Thrombocytopaenia Among Patients Attending Primary Care Clinics.

Authors:  Tong Seng Fah; Noorazah Abdul Aziz MMed; Chin Gek Liew; Khairani Omar
Journal:  Malays Fam Physician       Date:  2006-04-30

9.  Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control.

Authors:  Joseph R Egger; Eng Eong Ooi; David W Kelly; Mark E Woolhouse; Clive R Davies; Paul G Coleman
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

10.  Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004.

Authors:  Joan Marie Brunkard; Jose Luis Robles López; Josue Ramirez; Enrique Cifuentes; Stephen J Rothenberg; Elizabeth A Hunsperger; Chester G Moore; Regina M Brussolo; Norma A Villarreal; Brent M Haddad
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.